姜润学, 胡万宁, 孙国贵. The effect of BTG1 overexpression on the proliferation and apoptosis of laryngeal cancer cells and its molecular mechanism in vitro[J]. China Oncology, 2015, 25(12): 959-965.
姜润学, 胡万宁, 孙国贵. The effect of BTG1 overexpression on the proliferation and apoptosis of laryngeal cancer cells and its molecular mechanism in vitro[J]. China Oncology, 2015, 25(12): 959-965. DOI: 10.3969/j.issn.1007-3969.2015.12.007.
背景与目的:在多种细胞中B细胞易位基因1(B-cell translocation gene 1,BTG1)能够抑制细胞增殖,促进细胞凋亡,调节细胞周期进程及分化。该研究通过体外实验探讨BTG1高表达对喉癌Hep-2细胞增殖、凋亡及细胞周期的影响及其相关作用机制。方法:构建pEGFP-N1-BTG1,培养并转染喉癌Hep-2细胞,分为实验组(转染pEGFP-N1-BTG1的Hep-2细胞)和对照组(转染pEGFP-N1空质粒的Hep-2细胞)。采用蛋白[质]印迹法(Western blot)检测两组细胞中BTG1蛋白的表达水平;应用MTT法检测细胞的增值活性;使用流式细胞术检测细胞周期分布和磷脂酰丝氨酸外翻分析(Annexin Ⅴ-FITC/PI)检测细胞凋亡;采用Western blot法检测细胞周期调控蛋白Cyclin D1、凋亡相关蛋白Bcl-2表达情况。结果:成功构建pEGFP-N1-BTG1,Western blot检测结果显示,实验组细胞中BTG1蛋白表达水平明显高于对照组细胞(0.921±0.091 vs 0.308±0.047,P0.05)。实验组与对照组细胞相比,从第24 h实验组细胞生长速度减慢,细胞增值能力降低,两组比较差异有统计学意义(P0.05);实验组细胞中Cyclin D1蛋白表达水平下降(0.436±0.023 vs 0.916±0.092,P0.05),细胞周期的G
0
/G
1
期细胞比例升高[(85.1±5.2)% vs (63.8±3.1)%,P0.05)];S期细胞比例降低[(8.3±1.1)% vs(23.1±1.5)%,P0.05];实验组细胞Annexin Ⅴ增多,细胞早期凋亡率升高[(10.3±1.1)% vs (2.8±0.3)%,P0.05],抗凋亡蛋白Bcl-2表达水平降低(0.167±0.009 vs 0.834±0.084,P0.05)。结论:BTG1高表达能明显抑制喉癌Hep-2细胞的生长增殖、诱导凋亡,其可能的机制与BTG1参与细胞周期调控、诱导细胞凋亡相关。
Abstract
Background and purpose: B-cell translocation gene 1(BTG1) can inhibit cell proliferation
promote cell apoptosis and regulate cell cycle progression and differentiation in a variety of cell types. This study aimed to explore the influence on cell proliferation
apoptosis and cell cycle
and its related mechanism of laryngeal cancer Hep - 2 cell lines through BTG1 overexpression by in vitro experiments. Methods: The BTG1 expression plasmids were constructed and transfected into Hep-2. They were divided into experimental group (transfected BTG1 of Hep-2 cells) and control group (transfected empty plasmid of Hep-2 cells). Western blot method was used to identify BTG1 protein expression levels of cells; proliferation activity of cells was detected by MTT assay; flow cytometry was used to analyze the cell cycle distribution and Annexin Ⅴ-FITC/PI cell apoptosis; Western blot was also used to assay cell cycle regulatory protein and apoptosis-related protein expression. Results: The pEGFP-N1-BTG1 plasmid was constructed successfully
and the expression of BTG1 protein was higher in experimental group than that in control group (0.921±0.091 vs 0.308±0.047
P0.05). Compared with the two group of laryngeal cancer Hep-2 cells
the cell growth in experimental group was slowed down and the proliferation was reduced (P0.05); Cyclin D1 protein expression level was decreased (0.436±0.023 vs 0.916±0.092
P0.05)
the proportion of G
0
/G
1
phase cell cycle was increased [(85.1±5.2)% vs (63.8±3.1)%
P0.05
]
the proportion of S phase cell was decreased [(8.3±1.1)% vs (23.1±1.5)%
P0.05
]
phosphatidylserine ectropion in experimental group was increased
cell early apoptosis was significant [(10.3±1.1)% vs (2.8±0.3)%
P0.05
]
and anti-apoptotic protein Bcl-2 expression level was reduced(0.167±0.009 vs 0.834±0.084
P0.05). Conclusion: BTG1 high expression could inhibit the proliferation growth of laryngeal Hep-2 cells and promote its apoptosis
and the possible mechanisms are interrelated with BTG1 involved in cell cycle regulation and causing cell apoptosis.